APP protein plays a central role in the development of Alzheimer’s disease; its expression, metabolism, splicing and secretion have been demonstrated to be regulated by ligands of the membrane tyrosine kinase receptors like BDNF [54]. This evidence concerns the gene APP and early-onset autosomal dominant Alzheimer disease.